Literature DB >> 29404727

Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.

Chiara Sassoli1, Larissa Vallone2, Alessia Tani2, Flaminia Chellini2, Daniele Nosi2, Sandra Zecchi-Orlandini2.   

Abstract

Satellite cell-mediated skeletal muscle repair/regeneration is compromised in cases of extended damage. Bone marrow mesenchymal stromal cells (BM-MSCs) hold promise for muscle healing but some criticisms hamper their clinical application, including the need to avoid animal serum contamination for expansion and the scarce survival after transplant. In this context, platelet-rich plasma (PRP) could offer advantages. Here, we compare the effects of PRP or standard culture media on C2C12 myoblast, satellite cell and BM-MSC viability, survival, proliferation and myogenic differentiation and evaluate PRP/BM-MSC combination effects in promoting myogenic differentiation. PRP induced an increase of mitochondrial activity and Ki67 expression comparable or even greater than that elicited by standard media and promoted AKT signaling activation in myoblasts and BM-MSCs and Notch-1 pathway activation in BM-MSCs. It stimulated MyoD, myogenin, α-sarcomeric actin and MMP-2 expression in myoblasts and satellite cell activation. Notably, PRP/BM-MSC combination was more effective than PRP alone. We found that BM-MSCs influenced myoblast responses through a paracrine activation of AKT signaling, contributing to shed light on BM-MSC action mechanisms. Our results suggest that PRP represents a good serum substitute for BM-MSC manipulation in vitro and could be beneficial towards transplanted cells in vivo. Moreover, it might influence muscle resident progenitors' fate, thus favoring the endogenous repair/regeneration mechanisms. Finally, within the limitations of an in vitro experimentation, this study provides an experimental background for considering the PRP/BM-MSC combination as a potential therapeutic tool for skeletal muscle damage, combining the beneficial effects of BM-MSCs and PRP on muscle tissue, while potentiating BM-MSC functionality.

Entities:  

Keywords:  AKT signaling; Bone marrow-derived mesenchymal stromal cells (BM-MSCs); Paracrine factors; Platelet-rich plasma (PRP); Skeletal muscle regeneration

Mesh:

Substances:

Year:  2018        PMID: 29404727     DOI: 10.1007/s00441-018-2792-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  17 in total

Review 1.  In vitro evidence supporting applications of platelet derivatives in regenerative medicine.

Authors:  Ilaria Giusti; Sandra D'Ascenzo; Guido Macchiarelli; Vincenza Dolo
Journal:  Blood Transfus       Date:  2019-10-08       Impact factor: 3.443

2.  Red (635 nm), Near-Infrared (808 nm) and Violet-Blue (405 nm) Photobiomodulation Potentiality on Human Osteoblasts and Mesenchymal Stromal Cells: A Morphological and Molecular In Vitro Study.

Authors:  Alessia Tani; Flaminia Chellini; Marco Giannelli; Daniele Nosi; Sandra Zecchi-Orlandini; Chiara Sassoli
Journal:  Int J Mol Sci       Date:  2018-07-03       Impact factor: 5.923

3.  Bone marrow mesenchymal stem cells combine with normothermic machine perfusion to improve rat donor liver quality-the important role of hepatic microcirculation in donation after circulatory death.

Authors:  Liu Yang; Huan Cao; Dong Sun; Bin Hou; Ling Lin; Zhong-Yang Shen; Hong-Li Song
Journal:  Cell Tissue Res       Date:  2020-04-29       Impact factor: 5.249

4.  Myogenic differentiation of primary myoblasts and mesenchymal stromal cells under serum-free conditions on PCL-collagen I-nanoscaffolds.

Authors:  Aijia Cai; Moritz Hardt; Paul Schneider; Rafael Schmid; Claudia Lange; Dirk Dippold; Dirk W Schubert; Anja M Boos; Annika Weigand; Andreas Arkudas; Raymund E Horch; Justus P Beier
Journal:  BMC Biotechnol       Date:  2018-11-26       Impact factor: 2.563

5.  Platelet-Rich Plasma Prevents In Vitro Transforming Growth Factor-β1-Induced Fibroblast to Myofibroblast Transition: Involvement of Vascular Endothelial Growth Factor (VEGF)-A/VEGF Receptor-1-Mediated Signaling .

Authors:  Flaminia Chellini; Alessia Tani; Larissa Vallone; Daniele Nosi; Paola Pavan; Franco Bambi; Sandra Zecchi Orlandini; Chiara Sassoli
Journal:  Cells       Date:  2018-09-19       Impact factor: 6.600

6.  Shockwave Therapy Combined with Autologous Adipose-Derived Mesenchymal Stem Cells Is Better than with Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells on Knee Osteoarthritis.

Authors:  Chieh-Cheng Hsu; Jai-Hong Cheng; Ching-Jen Wang; Jih-Yang Ko; Shan-Ling Hsu; Tsai-Chin Hsu
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

7.  Thioredoxin mitigates H2 O2 -induced inhibition of myogenic differentiation of rat bone marrow mesenchymal stem cells by enhancing AKT activation.

Authors:  Meiling Liu; Xianglu Li; Changlin Zhou; Manfeng Wang; Hongzhi Wang; Haifeng Ding; Luyang Cheng; Lu Gan; Xiaowei Wu; Zhimin Du
Journal:  FEBS Open Bio       Date:  2020-04-02       Impact factor: 2.693

8.  Platelet-Rich Plasma Modulates Gap Junction Functionality and Connexin 43 and 26 Expression During TGF-β1-Induced Fibroblast to Myofibroblast Transition: Clues for Counteracting Fibrosis.

Authors:  Roberta Squecco; Flaminia Chellini; Eglantina Idrizaj; Alessia Tani; Rachele Garella; Sofia Pancani; Paola Pavan; Franco Bambi; Sandra Zecchi-Orlandini; Chiara Sassoli
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

9.  Responses of canine periodontal ligament cells to bubaline blood derived platelet rich fibrin in vitro.

Authors:  Poranee Banyatworakul; Thanaphum Osathanon; Sujin Chumprasert; Prasit Pavasant; Nopadon Pirarat
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

Review 10.  Current Strategies for the Regeneration of Skeletal Muscle Tissue.

Authors:  Emine Alarcin; Ayca Bal-Öztürk; Hüseyin Avci; Hamed Ghorbanpoor; Fatma Dogan Guzel; Ali Akpek; Gözde Yesiltas; Tuba Canak-Ipek; Meltem Avci-Adali
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.